Info About Peptides

Peptide Bioregulation and the Era of Active Longevity

The modern education system traditionally focuses on academic disciplines, completely ignoring health preservation, the development of the body’s internal reserves and the improvement of the quality of life, as well as preventive gerontology and the maintenance of active longevity. Biology classes cover basic anatomy but miss out on biohacking, stress management and preventive medicine.

On the critique of school education and healthy lifestyle: A reference to the World Health Organization (WHO) reports on Health Literacy. The WHO officially states in its School Health Literacy Report that schools do not provide sufficient health preservation skills.

Treatment vs. Prevention: The Modern Imbalance

The public healthcare system is built on a model where therapy begins only at the stage when age-dependent pathologies manifest (such as arterial hypertension, metabolic syndrome, type II diabetes, gout, etc.). A preventive (geroprotective) approach aimed at addressing the biochemical markers of aging is, as a rule, not applied.

Consequently, the number of individuals who maintain a high viability index, biochemical homeostasis and an optimal biological age (according to the F. Bourlière scale) remains critically low in most modern societies.

Recently, people have increasingly been turning to self-education to make up for the shortcomings of the traditional school system. Internet resources, medical blogs, podcasts and popular science literature allow individuals to fill these knowledge gaps on their own. The trend toward a healthy lifestyle, preventive medicine and mental health is gaining traction among the younger and middle-aged generations. As a result, health literacy in society is gradually rising.

From Lifespan to Healthspan: The Peptide Revolution

Modern gerontology focuses not merely on extending lifespan, but on expanding healthspan—preserving both cognitive and physical functions. A fundamental shift in this direction occurred thanks to the concept of peptide bioregulation developed by the Russian scientists under the leadership of Prof. Vladimir Khavinson. His leadership in the global scientific community is confirmed by his tenure as President of the European Region of the International Association of Gerontology and Geriatrics (IAGG-ER) from 2011 to 2015.

Due to stress, poor environmental conditions and diseases, gene expression becomes disrupted, causing cells to age prematurely. Short peptides (Khavinson peptides) are capable of binding to DNA, activating transcription (gene expression) and subsequent protein synthesis, thereby restoring the functional activity of tissues. The precise mechanisms of this process are extensively detailed in peer-reviewed studies on PubMed: Peptide Bioregulation of Aging.

The Legacy of Francois Bourliere: Adding Life to Years

One of the founding fathers of the modern concept of healthy aging was Francois Bourliere (1913–1993) - an outstanding French gerontologist and ecologist and Director of the Paris Centre of Gerontology. He is credited with the aphorism: "Today, the problem is not to add years to life, but to add life to years." 

Prof.F.Bourliere was among the first to prove that aging is not a disease to be treated with hormones or halted by radical methods. The secret to longevity lies in prevention, the preservation of cognitive functions, dietary adaptation and maintaining an active lifestyle.

Prof.F.Bourliere developed the first tests for assessing biological age. He proved that chronological age and the actual state of cells are completely different things. A person can be frail and biologically elderly at 50 or remain biologically young at 75.

Short Peptides: The Longevity Ideal

Short peptides function exactly as Bourliere envisioned: instead of artificially supporting a fading organism, they restore protein synthesis at the cellular level, bringing functional activity back to organs.

Clinical studies conducted by the V.Kh. Khavinson Institute have proven that the application of peptides reduces mortality and significantly enhances the body's resources, which is backed by long-term data in the Khavinson Institute Mortality Study. Peptides do not promise fantastic immortality; instead, they deliver the most valuable asset -active longevity. They protect tissues from wear and tear, preserve health and help to live long while staying young.

But first: What actually are peptides?

Peptides are a large class of protein-based substances, often described as "short proteins" containing up to 100 amino acids. This class includes vital hormones, enzymes, antibodies and peptide bioregulators. Peptide bioregulators are very short chains of amino acids (5-20 amino acids long in Cytomaxes, 2-3 in Cytogens) that signal the synthesis of new proteins when cell renewal is required in a specific organ or tissue.

The medical use of peptides began in the first half of the 20th century. The first drug of this kind was the peptide hormone insulin, successfully used in 1922 to treat diabetes. For a long time, peptide drugs were used primarily as replacement therapy to compensate for endogenous hormone deficiencies. Today, peptides are effectively used to treat cancer, metabolic disorders (type 2 diabetes, obesity), cardiovascular pathologies, autoimmune diseases and other conditions.

The peptide drug market is a rapidly growing and promising innovative segment of the economy. Peptide therapeutics are being actively developed by leading pharmaceutical companies worldwide. More than 80 peptide therapeutics have been approved globally and clinical trials for over 100 more are underway.
The most popular categories include:

• Weight loss & Metabolic health: Semaglutide (Ozempic), Liraglutide
• Cosmetics: Matrixyl 3000, Argireline, SYN-AKE, GHK-Cu
• Sports & Recovery: BPC-157, TB-500
• Wellness: peptides for stimulating natural growth hormone production, improving sleep quality and fat burning.
  
  

Peptide Bioregulation & Longevity: The Khavinson School

Discovered by Russian military scientists led by Professor Vladimir Khavinson, these peptide bioregulators hold a unique place in modern anti-aging medicine. Unlike traditional hormone replacement therapy, which can shut down your body's natural hormone production, peptides work through "physiological replenishment." Instead of just masking symptoms, they reboot protein synthesis at the cellular level, helping your tissues repair themselves naturally.

Ultra-short peptides possess unique properties:

• DNA Activation: they easily penetrate cells to interact with your DNA, "switching on" genes responsible for youth and repair.This stimulates the cell of the aging organ to synthesize proteins in the same volume as it did in youth. Unlike artificial testosterone or estrogen, which disable the production of natural hormones, peptides do not cause withdrawal symptoms or glandular atrophy.
• Tissue specificity: peptides are strictly tissue-specific. Heart peptides optimize cardiac function, while pineal gland peptides boost natural melatonin production and fix sleep cycles.
• Proven Longevity: extensive studies show these molecules can extend animal lifespans by 30–40% by unlocking deep cellular reserves.

Khavinson's Classification of Bioregulators

• Cytomaxes: Natural peptide extracts obtained through the multi-stage purification of young animal tissues. They have a profound, gentle, and prolonged effect.
• Cytogens: Short amino acid chains synthesized in a laboratory setting that completely replicate the most active sites of natural peptides. They act faster than cytomaxes but have a shorter aftereffect period.
• Revilab (Complexes): Multi-component anti-aging products developed using synthesized Khavinson peptides(cytogens). Each product includes not only a complex of peptide bioregulators - three to four types - but also additional active ingredients.
• Pharmaceutical-grade injectable peptide bioregulators - specifically preparations for the thymus (Thymalin ), pineal gland (Pineamin), retina (Retinalamin), polypeptides of the cerebral cortex (Cortexin) and prostate gland peptides (Prostatilen) - have undergone comprehensive clinical trials and are registered as official medicines by the Ministry of Health.

Comparative Analysis: Russian Peptides vs. Western Analogues.

The Western longevity market developed differently. While Professor V. Khavinson focused on short-chain amino acids (bioregulators) isolated from animal organs, the American industry followed the path of hormone therapy (HRT), synthetic peptides and growth factor stimulators.